Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation

NCT01581177 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Albuterol DPI 25 mcg/inh
DRUG: Albuterol DPI 90 mcg/inh
DRUG: Placebo DPI
DRUG: Albuterol MDI 90 mcg/inh

Sponsor

Amphastar Pharmaceuticals, Inc.